Shah Dishan D, Taylor Lynne S
Department of Industrial and Molecular Pharmaceutics, College of Pharmacy, Purdue University, West Lafayette, IN 47907, United States; Integrated Product Development Organization, Dr. Reddy's Laboratories, Bachupally, Hyderabad, Telangana 500090, India.
Department of Industrial and Molecular Pharmaceutics, College of Pharmacy, Purdue University, West Lafayette, IN 47907, United States.
J Pharm Sci. 2025 Jan;114(1):223-233. doi: 10.1016/j.xphs.2024.08.023. Epub 2024 Sep 5.
Hydroxypropyl methyl cellulose acetate succinate (HPMCAS) is one of the polymers of choice in formulating amorphous solid dispersions (ASDs) and helps to sustain high levels of drug supersaturation by delaying drug crystallization. Herein, the impact of HPMCAS chemistry on the solution crystallization kinetics of a fast-crystallizing lipophilic drug, posaconazole (PCZ), from the aqueous bulk phase and the drug-rich phase generated by liquid-liquid phase separation (LLPS), was studied. Three grades of HPMCAS: L, M, and H, which differ in the degree of acetyl and succinoyl substitution (A/S ratio), were compared. The influence of the polymers on the nucleation induction time, and LLPS concentration of PCZ, as well as the size, ζ-potential and composition of the nano-sized drug-rich phase was determined. An increase in the nucleation induction time was observed with an increase in the polymer A/S ratio. A blue shift in the fluorescence emission spectrum of PCZ suggested a greater extent of interaction between PCZ and HPMCAS with an increase in the A/S ratio. More polymer partitioning into the drug-rich phase was also observed with an increase in the A/S ratio, resulting in smaller droplets. A greater extent of ionization of HPMCAS upon increasing the pH from 5.5 to 7.5 decreased the hydrophobicity of the polymer resulting in shorter nucleation induction times. The phase behavior of PCZ in ASD release studies was consistent with these observations, where the shortest duration of supersaturation was observed with the L grade. Although the H grade provided the best inhibition of crystallization, complete release was only observed at higher pH. HPMCAS grade thus influences the kinetics of PCZ crystallization following release from an ASD, as well as the extent of release at physiologically relevant pH conditions. This study provides insights into the role of HPMCAS chemistry and ionization as factors influencing its ability to act as a crystallization inhibitor.
羟丙基甲基纤维素乙酸琥珀酸酯(HPMCAS)是制备无定形固体分散体(ASD)时的首选聚合物之一,它通过延迟药物结晶来维持高水平的药物过饱和度。在此,研究了HPMCAS化学性质对快速结晶的亲脂性药物泊沙康唑(PCZ)从水相主体以及液-液相分离(LLPS)产生的富药相中的溶液结晶动力学的影响。比较了三种乙酰基和琥珀酰基取代度(A/S比)不同的HPMCAS等级:L、M和H。测定了聚合物对PCZ成核诱导时间、LLPS浓度以及纳米级富药相的尺寸、ζ电位和组成的影响。随着聚合物A/S比的增加,观察到成核诱导时间增加。PCZ荧光发射光谱的蓝移表明,随着A/S比的增加,PCZ与HPMCAS之间的相互作用程度更大。随着A/S比的增加,还观察到更多的聚合物分配到富药相中,导致液滴更小。将pH从5.5提高到7.5时,HPMCAS的电离程度增加,降低了聚合物的疏水性导致成核诱导时间缩短。PCZ在ASD释放研究中的相行为与这些观察结果一致,其中L等级观察到的过饱和持续时间最短。尽管H等级对结晶的抑制效果最佳,但仅在较高pH下观察到完全释放。因此,HPMCAS等级影响PCZ从ASD释放后的结晶动力学,以及在生理相关pH条件下的释放程度。本研究深入探讨了HPMCAS化学性质和电离作为影响其作为结晶抑制剂能力的因素所起的作用。